Use of aerosolized inhaled iloprost in the treatment of portopulmonary hypertension

被引:23
作者
Halank, M [1 ]
Marx, C [1 ]
Miehlke, S [1 ]
Hoeffken, G [1 ]
机构
[1] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Internal Med 1, D-01307 Dresden, Germany
关键词
D O I
10.1007/s00535-004-1478-7
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:1222 / 1223
页数:3
相关论文
共 4 条
[1]   Distinctive clinical features of portopulmonary hypertension [J].
Kuo, PC ;
Plotkin, JS ;
Johnson, LB ;
Howell, CD ;
Laurin, JM ;
Bartlett, ST ;
Rubin, LJ .
CHEST, 1997, 112 (04) :980-986
[2]   Continuous intravenous infusion of epoprostenol for the treatment of portopulmonary hypertension [J].
Kuo, PC ;
Johnson, LB ;
Plotkin, JS ;
Howell, CD ;
Bartlett, ST ;
Rubin, LJ .
TRANSPLANTATION, 1997, 63 (04) :604-606
[3]   Inhaled iloprost for severe pulmonary hypertension [J].
Olschewski, H ;
Simonneau, G ;
Galiè, N ;
Higenbottam, T ;
Naeije, R ;
Rubin, LJ ;
Nikkho, S ;
Speich, R ;
Hoeper, MM ;
Behr, J ;
Winkler, J ;
Sitbon, O ;
Popov, W ;
Ghofrani, HA ;
Manes, A ;
Kiely, DG ;
Ewert, R ;
Siedentop, H ;
Seeger, W .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (05) :322-329
[4]   Use of aerosolized inhaled epoprostenol in the treatment of portopulmonary hypertension [J].
Schroeder, RA ;
Rafii, AA ;
Plotkin, JS ;
Johnson, LB ;
Rustgi, VK ;
Kuo, PC .
TRANSPLANTATION, 2000, 70 (03) :548-550